Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1981 Apr;43(4):505-16.
doi: 10.1038/bjc.1981.73.

Immune response to chemically induced tumours: correlation of responding cell class with in vivo inhibition of tumour growth

Free PMC article

Immune response to chemically induced tumours: correlation of responding cell class with in vivo inhibition of tumour growth

M B Calderwood et al. Br J Cancer. 1981 Apr.
Free PMC article

Abstract

Lymphoid cells stimulated by soluble tumour antigens in the MCA-induced murine fibrosarcoma system have been identified by subclass and protective capacity in adoptive syngeneic hosts. Lymph-node or spleen cells taken at weekly intervals after inoculation of syngeneic chemically induced fibrosarcomas were enriched by 3 methods in T, B, and "null" cell subclasses, and assayed for proliferative kinetics in response to soluble membrane antigens. The stimulated subpopulations were found to be heterogeneous, their composition varying with time and tumour burden. Initial proliferative responses after tumour inoculation were limited to the T-enriched subpopulation. Later during tumour growth, T, B and null cell fractions were vigorously and equally stimulated by tumour antigen. The ability of the same T, B or null-cell subpopulations to inhibit tumour growth was measured in adoptive hosts by a modified Winn assay. Only the T-cell subpopulation responding to tumour antigen in vitro effectively and consistently retarded tumour growth in vivo. In contrast to the shared specificities on syngeneic tumours identified by the proliferative assay, tumour-growth inhibition was limited to the specific tumour borne by the cell donor.

PubMed Disclaimer

References

    1. J Exp Med. 1970 Jun 1;131(6):1049-78 - PubMed
    1. J Immunol. 1961 Feb;86:228-39 - PubMed
    1. J Immunol. 1970 Oct;105(4):984-1000 - PubMed
    1. Science. 1971 Jun 11;172(3988):1134-6 - PubMed
    1. Cell Immunol. 1971 Aug;2(4):353-61 - PubMed

Publication types